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Paramagnetic and superparamagnetic substances are used to trace stem cell in living organisms
under magnetic resonance imaging MRI. We compared paramagnetic and superparamagnetic
substance for their labeling efficiency by using clinically widely used gadolinium chelates and iron
oxide nanoparticles. Without the aid of transfection agent, human mesenchymal stem cells were
labeled with each agent separately in different concentration and the optimized concentration was
determined by maintaining same cell viability as unlabeled cells. Iron oxide nanoparticle labeling
has a detecting threshold of 12 500 cells in vitro, while gadolinium chelates labeling could be
detected for at least 50 000 cells. In life animal study, we found there is an eightfold sensitivity in
cells labeled with iron oxide superparamagnetic nanoparticles; however, the magnetic susceptibility
artifact would obscure the detail of adjacent anatomical structures. We conclude that labeling stem
cells with superparamagnetic substance is more efficacious. However, the cells labeled by
superparamagnetic nanoparticles might interfere with the interpretation of anatomical structure.
These findings would be beneficial to applications of magnetic substances toward stem cell biology
and tissue engineering. © 2009 American Institute of Physics. DOI: 10.1063/1.3072821
I. INTRODUCTION
Mesenchymal stem cell MSC is a specific type of mul-
tipotent stem cell that is capable to differentiate into bone,
muscle, cartilage, fat, and other tissues. The current thera-
peutic applications of MSC include gene therapy and tissue
engineering through local delivery or systemic infusion
transplantation.1,2 Once stem cells are delivered into the hu-
man body, it is very important to follow the existence, the
growth or proliferation of the cells, and to trace its migration
between different organs.3 With the current methodologies, it
is difficult to study these parameters in vivo.
Magnetic resonance imaging MRI has much more flex-
ible intrinsic contrast than any other clinical imaging modal-
ity. The administration of magnetic contrast agents can
modify intrinsic magnetic parameters and provides greater
contrast between normal and diseased tissue.4 In molecular
and cellular imaging, paramagnetic and superparamagnetic
substances are used as contrast agents for labeling stem cells
so that the cells could be visualized on MRI.5 However, the
efficacy, sensitivity, and feasibility between paramagnetic
and superparamagnetic substances labeling were not fully in-
vestigated. Moreover, most of the labeling required transfec-
tion agent that might influence the cell behavior. We previ-
ously developed cell labeling without transfection agent and
in this study, human MSCs hMSCs labeled with paramag-
netic and superparamagnetic materials were tested to evalu-
ate the influence on the cells and the MRI characters of these
substances.
II. EXPERIMENT
In order to check the magnetic properties of gadodia-
mide, magnetic hysteresis measurements at room tempera-
ture were carried out by using a Quantum Design MPMS
SQUID magnetometer with the applied magnetic field up to
3 T. The magnetic properties of ferucarbotran were measured
previously.6
hMSCs immortalized by gene transfer of combination
of human telomerase reverse transcriptase with human
papilloma virus E6 and E7 were cultured as described.7
hMSCs were incubated with either superparamagnetic
substance, ferucarbotran Resovist, Schering AG, Berlin,
Germany; or paramagnetic substance, gadodiamide Omnis-
can, GE Healthcare, Waukesha, Wisconsin, U.S.; R1 /R2
=3.9 /4.3 s−1 mM−1 nanoparticles of different concentration
for the following examination.
For the labeling of hMSCs, the cells were seeded with
1105 cells per well in six-well plates and were allowed to
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attach for 24 h. After 24 h of incubation of ferucarbotran or
gadodiamide in different concentrations without any trans-
fection agent, flow cytometry was used to determine the cell
size and granularity change.7 Reactive oxygen species ROS
production of hMSCs after particles administration was
measured with flow cytometry using a dichlorofluorescein
diacetate fluorescent probe.8 Mitochondria membrane
potential MMP in hMSCs was measured with fluorescent
intensities analyzed by flow cytometry.9 MTT 3-4,5-
Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide as-
say was used with a microplate reader to evaluate cell viabil-
ity and proliferation.7
The enhancement of untreated and a series of diluted
labeled 1000 to 2105 hMSCs were evaluated using two-
dimensional T2-weighted gradient echo pulse sequence with
a clinical 1.5 T MR System Signa Excite, GE Healthcare,
USA and an eight-channel head coil.10 Male BALB/c mice
8 weeks of age were obtained from National Laboratory
Animal Center, Taiwan. The labeled cells 1105 cells/
100ul were injected subcutaneously into the dorsal thighs of
the mice. Five hours later, animal MRI studies were per-
formed under intraperitoneal anesthesia. The mice were then
scanned with a custom-made radiofrequency coil in the same
clinical 1.5 T MR system as in vitro study.10
III. RESULTS AND DISCUSSION
A. Cell culture and flow cytometry detection
Gadodiamide revealed linear increase in magnetism that
comply with paramagnetic substance. Under 3 T magnetic
field, we measured 0.17 emg/g. The ferucarbotran revealed
superparamagnetism with satuation magnetization of 80
emu/g and the Hc is zero Fig. 1. We first tested the toxicity
of Gadodiamide with 0.95, 2.87, 9.53, or 28.7 mg/ml in hM-
SCs. We found mass cells death with 28.7 mg/ml of gadodia-
mide data not shown. Further analysis will be required to
elucidate the toxicity of gadodiamide at this concentration.
Apoptosis has been observed in cells incubated with high
iron concentrations 500 g Fe/ml.11 We did not observe any
cells death or morphological change in hMSCs with 9.53
mg/ml of gadodiamide, nor for hMSCs with 10 g /ml of
ferucarbotran under light microscopy Figs. 2a–2c. Prus-
sian blue staining of ferucarbotran-labeled hMSCs also con-
firmed the uptake of iron content Fig. 2c.
Flow cytometric measurement confirmed that the label-
ing of ferucarbotran or gadodiamide did not influence the
forward and side light scattering FSC and SSC, respec-
tively of the stem cells Fig. 2d. The result suggests that
the concentration we used for labeling does not significantly
influence the cell size and granularity. The production of
ROS can result in lipid peroxidation and DNA damage and
ultimately causes toxic effect on cells. The ROS production
were not significantly altered in both paramagnetic and su-
perparamagnetic substance-labeled hMSCs when compared
with the unlabeled cells Fig. 2d. Mitochondrial perme-
ability transition is a central coordinating event of apoptosis,
and a number of apoptotic phenomena are triggered after
that.9 In this study Fig. 2d, there was no evidence of
compromised hMSCs viability when ferucarbotran at the
concentration of 10 g /ml or gadodiamide at the concentra-
tion of 9.53 mg/ml was used.
B. Cell viability and proliferation
As shown in Fig. 3, 4-hr or overnight treatment did not
result in significant difference in cell viability and it is less
than 10% difference as compared with the unlabeled cells.
FIG. 1. Magnetization curves of ferucarbotran a and gadodiamide b.
FIG. 2. Color online Light microscopic appearance of hMSCs a–c
and results of flow cytometry. There is no significant alteration of cell size
and morphology after labeling of gadodiamide b or ferucarbotran c com-
pared with unlabeled hMSCs a. d Flow cytometric measurement of cells
treated with different agents. The measurement of FSC and SSC was done 3
days after incubation with specific agents. The measurement of ROS and
MMP was done after 24 h of incubation with each agent.
FIG. 3. Color online Result of MTT assay after 4 h or overnight of mag-
netic particles labeling of hMSCs.
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The results suggest no significant alteration in MTT after
labeling of each magnetic particle in these concentrations.
C. In vitro MR imaging of labeled cell
First, we compared the labeling of 2105 cells of hM-
SCs with different amount of gadodiamide and 10 g /ml of
ferucarbotran. As shown in Fig. 4a, we found that the la-
beled cells can be detected even at the lowest concentration
of gadodiamide. Interestingly, the signal of hMSCs with the
highest concentration of gadodiamide is very low and this
may due to the mass cells’ death labeling. Second, we used
different numbers of hMSCs labeled with gadodiamide and
ferucarbotran under the optimal condition. Fig. 4b. We
found that gadodiamide-labeled hMSCs only can be detected
by MRI when cell number is greater than 50 000, conversely,
ferucarbotran-labeled hMSCs can be detected by MRI with
only 12 500 cells in the tube.
As expected, we could find that ferucarbotran as a nega-
tive contrast agent caused signal intensity drop not only at
the cells themselves but also the surrounding areas on the
MRI. The profound dark signal produced by the superpara-
magnetic material on MRI obscured the contour of the test
tube. On the contrary, cells labeled with the gadodiamide, a
positive contrast agent in this case, caused increased signal
intensity but only within the cells on the MRI Figs. 4a and
4b, which provides good contrast between hMSCs and
their surrounding environment.
D. MR imaging of labeled hMSCs in BALB/c mice
In life animal study, we first injected equal numbers of
different labeled cells to each thigh of mice. The side in-
jected with iron oxide superparamagnetic nanoparticle la-
beled cells appears as profound dark signal at the left thigh
right circle in Fig. 4c while the paramagnetic gadolinium
complex caused increased signal in intermuscular spaces, as
shown in Fig. 4c left circle. The affected area of MRI is
larger in ferucarbotran-labeled cells than in gadodiamide-
labeled cells, however, the magnetic susceptibility artifact
caused by paramagnetic nanoparticles interrupted the visual-
ization of adjacent structures. We also determined the mini-
mal number of labeled hMSCs that could be detected in life
animals by clinical MRI. As shown in Fig. 4d, we can use
1.25105 of ferucarbotran labeled cells to achieve similar
signal with 1106 of gadodiamide labeled cells. The higher
MRI sensitivity of superparamagnetic labeling is especially
useful when the injected stem cells are small in number. On
the other hand, to delineate the growth of the injected stem
cells, we could label the cells with paramagnetic particles.
The property of positive contrast agent makes it suitable for
labeling stem cells implanted into organs that appear dark on
MRI e.g., lungs. On the other hand, labeling with the nega-
tive contrast agent can be used in organs that appear as high
signal intensity, for example, kidney or lymphoid tissues.
The understanding of signal alteration by paramagnetic and
superparamagnetic substances helps physicians to label the
stem cells properly on target organ to be salvaged.
IV. CONCLUSION
We conclude that the labeling with specific dose of para-
magnetic and superparamagnetic substances does not alter
the morphology, cell size, granularity, MMP, MTT, or ROS
production of the hMSCs. MRI detection of stem cells la-
beled with superparamagnetic substance is more efficacious
and more sensitive, but in case the evaluation of organ struc-
ture is critical, paramagnetic labeling is more favored. These
findings would be beneficial for development of stem cell
biology and tissue engineering.
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FIG. 4. in vitro and in vivo MR imaging of hMSCs. Part a shows two
different sections of the MR imaging of 2105 labeled cells that have
incubated with different concentration of magnetic particles. Gradual in-
crease in intensity is noted with the increase of the gadodiamide concentra-
tion from 0 to 9.53 mg/ml. The signal intensity of 28.7 mg/ml gadodia-
mide labeling decreased as compared with that of 9.53 mg/ml gadodiamide
labeling a. Part b shows the MR imaging of different cell number from
1500 to 1105 incubated with either 9.53 mg/ml gadodiamide or
10 g /ml ferucarbotran. Part c is MR imaging of labeled hMSCs in a
BALB/c mouse. d The minimal number of labeled hMSCs that could be
detected in life animals by clinical MRI. There is an eightfold sensitivity in
cells labeled with iron oxide superparamagnetic nanoparticles.
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